Vincerx Pharma Inc. (VINC)
Vincerx Pharma Statistics
Share Statistics
Vincerx Pharma has 2.24M shares outstanding. The number of shares has increased by 70.56% in one year.
| Shares Outstanding | 2.24M |
| Shares Change (YoY) | 70.56% |
| Shares Change (QoQ) | 18.09% |
| Owned by Institutions (%) | 24.12% |
| Shares Floating | 1.92M |
| Failed to Deliver (FTD) Shares | 8.78K |
| FTD / Avg. Volume | 0.99% |
Short Selling Information
The latest short interest is 55.65K, so 0.15% of the outstanding shares have been sold short.
| Short Interest | 55.65K |
| Short % of Shares Out | 0.15% |
| Short % of Float | 0.18% |
| Short Ratio (days to cover) | 0.05 |
Valuation Ratios
The PE ratio is -12.51 and the forward PE ratio is -2.59. Vincerx Pharma's PEG ratio is 0.41.
| PE Ratio | -12.51 |
| Forward PE | -2.59 |
| PS Ratio | 0 |
| Forward PS | 0.1 |
| PB Ratio | 44.78 |
| P/FCF Ratio | -12.42 |
| PEG Ratio | 0.41 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Vincerx Pharma Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.63, with a Debt / Equity ratio of 0.22.
| Current Ratio | 2.63 |
| Quick Ratio | 2.63 |
| Debt / Equity | 0.22 |
| Total Debt / Capitalization | 18.23 |
| Cash Flow / Debt | -16.17 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -3.58% and return on capital (ROIC) is -310.47%.
| Return on Equity (ROE) | -3.58% |
| Return on Assets (ROA) | -2.2% |
| Return on Capital (ROIC) | -310.47% |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-956,119.05 |
| Employee Count | 42 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -99.26% in the last 52 weeks. The beta is 1.11, so Vincerx Pharma's price volatility has been higher than the market average.
| Beta | 1.11 |
| 52-Week Price Change | -99.26% |
| 50-Day Moving Average | 2.56 |
| 200-Day Moving Average | 9.09 |
| Relative Strength Index (RSI) | 25.36 |
| Average Volume (20 Days) | 883.63K |
Income Statement
| Revenue | n/a |
| Gross Profit | -915K |
| Operating Income | -42.61M |
| Net Income | -40.16M |
| EBITDA | -42.61M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -1.89 |
Balance Sheet
The company has 12.78M in cash and 2.5M in debt, giving a net cash position of 10.28M.
| Cash & Cash Equivalents | 12.78M |
| Total Debt | 2.5M |
| Net Cash | 10.28M |
| Retained Earnings | -159.11M |
| Total Assets | 14.95M |
| Working Capital | 6.32M |
Cash Flow
In the last 12 months, operating cash flow was -40.45M and capital expenditures 0, giving a free cash flow of -40.45M.
| Operating Cash Flow | -40.45M |
| Capital Expenditures | 0 |
| Free Cash Flow | -40.45M |
| FCF Per Share | -1.9 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VINC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -245.45% |
| FCF Yield | -2361.14% |
Analyst Forecast
The average price target for VINC is $40, which is 5094.8% higher than the current price. The consensus rating is "Buy".
| Price Target | $40 |
| Price Target Difference | 5094.8% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Stock Splits
The last stock split was on Jan 28, 2025. It was a backward split with a ratio of 1:20.
| Last Split Date | Jan 28, 2025 |
| Split Type | backward |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | -22.34 |
| Piotroski F-Score | 1 |